A breakthrough cancer protocol involving fourteen of the first 15 prostate cancer patients treated in a clinical trial of the gold nanoparticle-based, focal therapy showed no detectable signs of cancer a year after treatment, crossing a milestone in a decades long quest to develop a treatment that destroys tumors without the debilitating side effects of chemotherapy, invasive surgery and radiation. …